Ovarian Cancer Clinical Trial

Avelumab Program Rollover Study

Summary

The main purpose of this study is to monitor the safety and tolerability of avelumab in participants with solid tumors who continue treatment with avelumab under the same treatment regimen as in the parent avelumab study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participants under enrollment and treatment in an avelumab clinical study under the sponsorship of EMD Serono Research & Development Institute, Inc. / Merck KGaA, Darmstadt, Germany

Merck Serono Co., Ltd (Japan)
Participants currently enrolled in an avelumab parent study and are on active treatment with avelumab or in long-term survival follow-up after treatment
Participants on active treatment must agree to continue to use highly effective contraception (that is, methods with a failure rate of less than 1% per year) for both male and female participants if the risk of conception exists
Other protocol defined inclusion criteria could apply.

Exclusion Criteria:

Participants who are pregnant or breastfeeding
Participants still on active treatment: Known hypersensitivity to any of the study intervention ingredients
Participant has been enrolled in the comparator arm of avelumab parent study
Participant has been withdrawn from avelumab parent study for any reason
Any other reason that, in the opinion of the Investigator, precludes the participant from participating in the study
Other protocol defined exclusion criteria could apply.

Study is for people with:

Ovarian Cancer

Phase:

Phase 3

Estimated Enrollment:

205

Study ID:

NCT03815643

Recruitment Status:

Active, not recruiting

Sponsor:

EMD Serono Research & Development Institute, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 24 Locations for this study

See Locations Near You

HonorHealth Research Institute
Scottsdale Arizona, 85258, United States
Highlands Oncology Group
Fayetteville Arkansas, 72703, United States
University of California Davis Health System - Comprehensive Cancer Center
Sacramento California, 95817, United States
Providence Medical Foundation
Santa Rosa California, 95403, United States
St Joseph Heritage Healthcare
Santa Rosa California, 95403, United States
Norwalk Hospital - The Whittingham Cancer Center
Norwalk Connecticut, 06850, United States
Hematology - Oncology Associates of the Treasure Coast - Hematology-Oncology Associates of Treasure Coast
Port Saint Lucie Florida, 34952, United States
Northwest Georgia Oncology Centers
Marietta Georgia, 30060, United States
Maryland Oncology Hematology, P.A.
Rockville Maryland, 20850, United States
Michigan State University
Lansing Michigan, 48910, United States
Virginia Piper Cancer Institute
Minneapolis Minnesota, 55407, United States
Kansas City Research Institute, LLC - Phase I Unit
Kansas City Missouri, 64131, United States
University of Cincinnati - PARENT
Cincinnati Ohio, 45229, United States
Oncology Hematology Care
Cincinnati Ohio, 45242, United States
Oncology/Hematology Care Clinical Trials, LLC
Cincinnati Ohio, 45242, United States
OSU - James Comprehensive Cancer Center
Columbus Ohio, 43210, United States
Oregon Health & Science University
Portland Oregon, 97201, United States
Rhode Island Hospital
Providence Rhode Island, 02903, United States
Medical University of South Carolina (MUSC)
Charleston South Carolina, 29425, United States
Greenville Hospital System University Medical Center (ITOR) - Upstate Affiliate Organization
Greenville South Carolina, 29605, United States
The West Clinic
Germantown Tennessee, 38138, United States
SCRI - Tennessee Oncology
Nashville Tennessee, 37203, United States
University of Texas Southwestern Medical Center
Dallas Texas, 75390, United States
Oncology Consultants, P.A.
Houston Texas, 77030, United States
Henry Ford Hospital
San Antonio Texas, 78229, United States
University of Vermont Medical Center - Fletcher Allen Gastroenterology
Burlington Vermont, 05401, United States
Instituto Alexander Fleming
Ciudad Autonoma Buenos Aires , , Argentina
Clínica Universitaria Privada Reina Fabiola
Cordoba , , Argentina
Ballarat Health Services
Ballarat , , Australia
Monash Medical Centre Clayton
Clayton , , Australia
Centre Hospitalier de l'Ardenne - Pharmacie
Libramont , , Belgium
Clinique CHC MontLégia
Liège , , Belgium
Hospital de Câncer de Barretos - Fundação Pio XII
Barretos , , Brazil
MHAT for women's health - Nadezhda, OOD
Sofia , , Bulgaria
Nemocnice Rudolfa a Stefanie Benesov a.s. nemocnice Stredoceskeho kraje - parent
Benesov , , Czechia
Masarykuv onkologicky ustav - 300176866 Parent
Brno , , Czechia
CHU Besançon - Hôpital Jean Minjoz - Service d'oncologie Medicale
Besancon Cedex , , France
Centre Oscar Lambret - Service d'Oncologie medicale
Lille cedex , , France
ICO - Site Paul Papin - service d'oncologie medicale
Nantes Cedex 01 , , France
ICO - Site René Gauducheau - Service d'Oncologie medicale
Nantes Cedex 01 , , France
Centre Antoine Lacassagne - Service d'Hématologie Oncologie
Nice , , France
Institut Curie - site de Paris - Service d'Oncologie Médicale
Paris Cedex 05 , , France
CHU Bordeaux - Service d'Oncologie Médicale
Pessac , , France
Groupe Hospitalier Sud - Hôpital Haut-Lévêque - Unité d'Explorations Fonctionnelles Respiratoires
Pessac , , France
CHU Poitiers - Hôpital la Milétrie - service d'oncologie médicale
Poitiers cedex , , France
Centre Paul Strauss - Service de Médecine Oncologique
Strasbourg Cedex , , France
Hopital Larrey - Service de Pneumologie et Oncologie Thoracique
Toulouse Cedex 9 , , France
Universitaetsklinikum Essen - Westdeutsches Tumorzentrum
Essen , , Germany
Petz Aladar Egyetemi Oktato Korhaz - Pulmonologiai Osztaly
Gyor , , Hungary
Zala Varmegyei Szent Rafael Korhaz - Pulmonologiai Osztaly
Zalaegerszeg , , Hungary
Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli" - Dipartimento Oncologia
Napoli , , Italy
IOV - Istituto Oncologico Veneto IRCCS
Padova , , Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica
Roma , , Italy
Istituto Nazionale Tumori Regina Elena IRCCS - UOC Oncologia Medica A
Roma , , Italy
Istituto Clinico Humanitas - U.O. di Oncologia Medica ed Ematologia
Rozzano , , Italy
National Cancer Center Hospital (NCCH)
Chuo-ku , , Japan
National Cancer Center Hospital - Dept of Gastrointestinal Oncology
Chuo-ku , , Japan
Osaka Habikino Medical Center - Dept of Pulmonary Oncology
Habikino-shi , , Japan
Cancer Institute Hospital of JFCR - Dept of Respiratory Medicine
Koto-ku , , Japan
Kurume University Hospital - Dept of Lung Cancer Center
Kurume-shi , , Japan
Osaka City General Hospital - Dept of Clinical Oncology
Osaka-shi , , Japan
Tohoku University Hospital
Sendai-shi , , Japan
Osaka University Hospital - Dept of Gastrointestinal Surgery
Suita-shi , , Japan
Chungbuk National University Hospital
Cheongju-si , , Korea, Republic of
Chonnam National University Hwasun Hospital
Daejeon , , Korea, Republic of
National Cancer Center
Goyang , , Korea, Republic of
Gachon University Gil Medical Center
Incheon , , Korea, Republic of
Asan Medical Center
Seoul , , Korea, Republic of
Korea University Anam Hospital
Seoul , , Korea, Republic of
Samsung Medical Center
Seoul , , Korea, Republic of
Seoul National University Hospital
Seoul , , Korea, Republic of
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul , , Korea, Republic of
Health Pharma Professional Research S.A. de C.V.
Mexico , , Mexico
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy - Dept of Lungs and Chest Oncology
Warszawa , , Poland
Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj Napoca - Sectia Radioterapie III
Cluj Napoca , , Romania
S.C Radiotherapy Center Cluj S.R.L - Parent
Comuna Floresti , , Romania
Institutul Regional de Oncologie Iasi - Sectia Oncologie Medicala
Iasi , , Romania
Spitalul Clinic Municipal "Dr. Gavril Curteanu" Oradea - Centrul Oncologie Medicala
Oradea , , Romania
S.C Oncomed S.R.L - Specialitatea Oncologie Medicala
Timisoara , , Romania
RBIH "Kursk regional clinical oncology dispensary" of Kursk Region Healthcare Committee
Kursk , , Russian Federation
SBHI of Novosibirsk region "Novosibirsk Regional Oncological Dispensary"
Novosibirsk , , Russian Federation
BHI of Omsk region "Clinical Oncology Dispensary" - Building #2
Omsk , , Russian Federation
LLC "Medical Technologies" - Parent
Saint Petersburg , , Russian Federation
FSBI "National Medical Research Center for Oncology n.a. N.N. Petrov" of the MoH of the RF - Parent
Saint-Petersburg , , Russian Federation
Pavlov First Saint Petersburg State Medical University - PARENT
Saint-Petersburg , , Russian Federation
Hospital de la Santa Creu i Sant Pau - Dept of Oncology
Barcelona , , Spain
Hospital Universitari Vall d'Hebron - Oncology Dept.
Barcelona , , Spain
Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica
Madrid , , Spain
Hospital de Mataro - Servicio de Oncologia Medica
Mataro , , Spain
Songklanagarind Hospital - Department of Medicine
Songkla , , Thailand
Adana City Hospital - Parent Account
Adana , , Turkey
Ankara University Medical Faculty - Medical Oncology
Ankara , , Turkey
Hacettepe University Medical Faculty - Oncology
Ankara , , Turkey
Goztepe Prof. Dr. Suleyman Yalcin City Hospital - Medical Oncology
Istanbul , , Turkey
Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty - Medical Oncology
Istanbul , , Turkey
Medipol University Medical Faculty - Parent
Istanbul , , Turkey
Ege University Medical Faculty - PARENT
Izmir , , Turkey
Mersin University Medical Faculty - Medical Oncology
Mersin , , Turkey
CNE KHERSON REG ONCOLOGICAL DISPENSARY OF KHERSON RC - Day Hosp of Polycl with Outpatient Chemoth Room
Kherson , , Ukraine
Podilskyi Regional Oncological Center - Dept of Chemotherapy
Vinnytsia , , Ukraine
Sarah Cannon Research Institute UK
London , , United Kingdom
Mount Vernon Cancer Centre
Northwood , , United Kingdom
Derriford Hospital - Dept of Oncology Clinical Trials
Plymouth , , United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Phase:

Phase 3

Estimated Enrollment:

205

Study ID:

NCT03815643

Recruitment Status:

Active, not recruiting

Sponsor:


EMD Serono Research & Development Institute, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.